TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia
Clinical trial NCT01003379 · COMPLETED
Trial details
- NCT number
- NCT01003379
- Sponsor
- Targacept Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-11-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.